XML 16 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash Flows From Operating Activities:    
Net income (loss) $ 1,298,205 $ 764,102
Adjustments to reconcile net income (loss) to net cash flows from operating activities:    
Depreciation and amortization 540,959 625,625
Realized and unrealized losses (gains) on investments (13,153) (44,467)
Non-cash, stock-based compensation 24,897 20,619
Deferred tax expense (benefit) 308,610 558,423
Other, net (78,481) 17,976
Changes in current assets and current liabilities, net (65,303) 284,805
Net cash flows from operating activities 2,015,734 2,227,083
Cash Flows From Investing Activities:    
Purchases of marketable investment securities (801,916) (282,919)
Sales and maturities of marketable investment securities 675,162 107,768
Purchases of property and equipment (282,805) (324,105)
Capitalized interest related to FCC authorizations (Note 2) (765,239) (769,046)
Purchases of FCC authorizations, including deposits (Note 9)   (4,711,154)
Purchases of strategic investments   (90,381)
Other, net 16,773 22,666
Net cash flows from investing activities (1,158,025) (6,047,171)
Cash Flows From Financing Activities:    
Proceeds from issuance of convertible notes   1,000,000
Redemption and repurchases of senior notes (1,088,392) (900,000)
Repayment of long-term debt and capital lease obligations (32,651) (32,409)
Payments made to parent of transferred businesses   (7,098)
Net proceeds from Class A common stock options exercised and stock issued under the Employee Stock Purchase Plan 16,300 24,171
Debt issuance costs   (6,158)
Other, net (2,760) (349)
Net cash flows from financing activities (1,107,503) 78,157
Net increase (decrease) in cash, cash equivalents, restricted cash and cash equivalents (249,794) (3,741,931)
Cash, cash equivalents, restricted cash and cash equivalents, beginning of period (Note 5) 1,479,901 5,325,184
Cash, cash equivalents, restricted cash and cash equivalents, end of period (Note 5) $ 1,230,107 $ 1,583,253